Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 May;145(5):939-42.
doi: 10.1378/chest.14-0114.

Counterpoint: were industry-sponsored roflumilast trials appropriate? No

Comment

Counterpoint: were industry-sponsored roflumilast trials appropriate? No

Jason Rho et al. Chest. 2014 May.
No abstract available

PubMed Disclaimer

Comment in

  • Rebuttal from Drs Suissa and Rabe.
    Suissa S, Rabe KF. Suissa S, et al. Chest. 2014 May;145(5):942-3. doi: 10.1378/chest.14-0113. Chest. 2014. PMID: 24798832 No abstract available.
  • Roflumilast in COPD.
    Worndl E, Hunt EB, Kennedy MP, Henry MT, Plant BJ, Murphy DM. Worndl E, et al. Chest. 2015 Jul;148(1):e31. doi: 10.1378/chest.15-0664. Chest. 2015. PMID: 26149563 No abstract available.
  • Response.
    Rho J, Ho N, Prasad V. Rho J, et al. Chest. 2015 Jul;148(1):e31-e32. doi: 10.1378/chest.15-0837. Chest. 2015. PMID: 26149564 Free PMC article. No abstract available.

Comment on

References

    1. Ioannidis JP. Mega-trials for blockbusters. JAMA. 2013;309(3):239-240 - PubMed
    1. Nycomed’s novel COPD therapy roflumilast receives FDA approval. WorldPharmaNews website. http://www.worldpharmanews.com/nycomed/1600-nycomeds-novel-copd-therapy-.... Accessed March 13, 2012
    1. Forest Laboratories management discusses Q3 2012 results-earnings call transcript 2012. Seeking Alpha website. http://seekingalpha.com/article/320088-forest-laboratories-management-di.... Accessed October 2, 2012
    1. Rabe KF, Bateman ED, O’Donnell D, Witte S, Bredenbröker D, Bethke TD. Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2005;366(9485):563-571 - PubMed
    1. Bergmann JF. Roflumilast for chronic obstructive pulmonary disease. Lancet. 2005;366(9500):1845. - PubMed

MeSH terms